Non-water-suppressed proton MR spectroscopy improves spectral quality in the human spinal cord

Magnetic Resonance in Medicine

Volumn 69, Issue 5, 2013, Pages 1253-1260

  Hock, Andreas ^a   MacMillan, Erin L ^a,b   Fuchs, Alexander ^a   Kreis, Roland ^b   Boesiger, Peter ^a   Kollias, Spyros S ^c   Henning, Anke ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

in vivo; magnetic resonance spectroscopy; metabolite cycling; non water suppressed; spinal cord; VAPOR

Indexed keywords

ALIGNMENT; BIOMEDICAL SIGNAL PROCESSING; BIOMOLECULES; DATA ACQUISITION; DOSIMETRY; ELECTROCARDIOGRAPHY; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; VAPORS;

HIGH SIGNAL-TO-NOISE RATIO; IN-VIVO; LOW SIGNAL-TO-NOISE RATIO; NON-WATER-SUPPRESSED; POINT RESOLVED SPECTROSCOPIES; PROTON MR SPECTROSCOPY; SPINAL CORDS; STATIC MAGNETIC FIELDS;

SIGNAL TO NOISE RATIO;

ADULT; ARTICLE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; METABOLITE; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; SPINAL CORD;

ADULT; ALGORITHMS; ASPARTIC ACID; BODY WATER; CHOLINE; CREATINE; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINAL CORD;

EID: 84876477943     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24387     Document Type: Article

References (39)

1. Lin A, Ross BD, Harris K, Wong W,. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2005; 2: 197-214.
2. Henning A, Schar M, Kollias SS, Boesiger P, Dydak U,. Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med 2008; 59: 1250-1258.
3. Marliani AF, Clementi V, Albini Riccioli L, Agati R, Carpenzano M, Salvi F, Leonardi M,. Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. Am J Neuroradiol 2010; 31: 180-184.
4. Cooke FJ, Blamire AM, Manners DN, Styles P, Rajagopalan B,. Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn Reson Med 2004; 51: 1122-1128.
5. Marliani AF, Clementi V, Albini-Riccioli L, Agati R, Leonardi M,. Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 2007; 57: 160-163.
6. Hock A, Henning A, Schär M, Fuchs A, Kollias S, Boesiger P,. ECG-triggered FASTERMAP shimming allows for reproducible shim convergence in spinal cord spectroscopy. In: Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden, 2010. p. 5042.
7. Gomez-Anson B, MacManus DG, Parker GJ, Davie CA, Barker GJ, Moseley IF, McDonald WI, Miller DH,. In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 2000; 42: 515-517.
8. Kendi AT, Tan FU, Kendi M, Yilmaz S, Huvaj S, Tellioglu S,. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 2004; 46: 764-769.
9. Carew JD, Nair G, Pineda-Alonso N, Usher S, Hu X, Benatar M,. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011; 12: 185.
10. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, Cercignani M, Wimpey K, Miller DH, Thompson AJ,. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007; 130 (pt 8): 2220-2231.
11. Filippi M, Agosta F,. Imaging biomarkers in multiple sclerosis. J Magn Reson Imaging 2010; 31: 770-788.
12. Holly LT, Freitas B, McArthur DL, Salamon N,. Proton magnetic resonance spectroscopy to evaluate spinal cord axonal injury in cervical spondylotic myelopathy. J Neurosurg Spine 2009; 10: 194-200.
13. Edden RA, Bonekamp D, Smith MA, Dubey P, Barker PB,. Proton MR spectroscopic imaging of the medulla and cervical spinal cord. J Magn Reson Imaging 2007; 26: 1101-1105.
14. Tkác I, Gruetter R,. Methodology of 1 H NMR spectroscopy of the human brain at very high magnetic fields. Appl Magn Reson 2005; 29: 139-157.
15. Pfeuffer J, Juchem C, Merkle H, Nauerth A, Logothetis NK,. High-field localized 1H NMR spectroscopy in the anesthetized and in the awake monkey. Magn Reson Imaging 2004; 22: 1361-1372.
16. Dreher W, Leibfritz D,. New method for the simultaneous detection of metabolites and water in localized in vivo 1H nuclear magnetic resonance spectroscopy. Magn Reson Med 2005; 54: 190-195.
17. de Graaf RA,. In vivo NMR spectroscopy-principles and techniques, 2nd ed. John Wiley, Chichester, 2008.
18. MacMillan EL, Chong DGQ, Dreher W, Henning A, Boesch C, Kreis R,. Magnetization exchange with water and T1 relaxation of the downfield resonances in human brain spectra at 3.0 T. Magn Reson Med 2011; 65: 1239-1246.
19. Hock A, MacMillan EL, Fuchs A, Kreis R, Boesiger P, Kollias S, Henning A,. Non-water suppressed proton MR spectroscopy allows spectral quality improvement in the human cervical spinal cord. In: Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. p. 406.
20. Edden RA, Schar M, Hillis AE, Barker PB,. Optimized detection of lactate at high fields using inner volume saturation. Magn Reson Med 2006; 56: 912-917.
21. Henning A, Schar M, Schulte RF, Wilm B, Pruessmann KP, Boesiger P,. SELOVS: brain MRSI localization based on highly selective T1- and B1- insensitive outer-volume suppression at 3T. Magn Reson Med 2008; 59: 40-51.
22. Gruetter R, Tkác I,. Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med 2000; 43: 319-323.
23. Shen J, Rycyna RE, Rothman DL,. Improvements on an in vivo automatic shimming method [FASTERMAP]. Magn Reson Med 1997; 38: 834-839.
24. Loth F, Yardimci MA, Alperin N,. Hydrodynamic modeling of cerebrospinal fluid motion within the spinal cavity. J Biomech Eng 2001; 123: 71-79.
25. Bodenhausen G, Freeman R, Turner DL,. Suppression of artifacts in two-dimensional J spectroscopy. J Magn Reson 1977; 27: 511-514.
26. Hwang T-L, van Zijl PCM, Garwood M,. Asymmetric adiabatic pulses for NH selection. J Magn Reson 1999; 138: 173-177.
27. Tkac I, Starcuk Z, Choi IY, Gruetter R,. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999; 41: 649-656.
28. Henning A, Fuchs A, Murdoch JB, Boesiger P,. Slice-selective FID acquisition, localized by outer volume suppression (FIDLOVS) for (1)H-MRSI of the human brain at 7 T with minimal signal loss. NMR Biomed 2009; 22: 683-696.
29. Klose U,. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990; 14: 26-30.
30. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
31. Smith SA, Levante TO, Meier BH, Ernst RR,. Computer simulations in magnetic resonance. An object-oriented programming approach. J Mag Reson 1994; 106: 75-105.
32. Baker EH, Basso G, Barker PB, Smith MA, Bonekamp D, Horska A,. Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging 2008; 27: 489-499.
33. Kreis R,. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004; 17: 361-381.
34. MacMillan EL, Bortolotti M, Boss A, Boesch C, Kreis R,. Metabolite cycled non-water-suppressed spectroscopy offers increased spectral quality in cases of physiologic and subject motion. In: Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. p. 406.
35. Bernstein MA, King KF, Zhou XJ,. Handbook of MRI pulse sequences: Elsevier Inc.; 2005.
36. Hock A, Valkovic L, Frollo I, Boesiger P, Henning A, Kollias S,. Real-time navigator gating in proton liver spectroscopy at 3T. In: Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. p. 2995.
37. Michaelis T, Helms G, Merboldt KD, Hanicke W, Bruhn H, Frahm J,. Identification of Scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed 1993; 6: 105-109.
38. Seaquist ER, Gruetter R,. Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR. Magn Reson Med 1998; 39: 313-316.
39. Kaiser LG, Schuff N, Cashdollar N, Weiner MW,. Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla. NMR Biomed 2005; 18: 51-55.